DNA binding-independent anti-proliferative action of benzazolo[3,2-α]quinolinium DNA intercalators

Molecular and Cellular Biochemistry

Volumn 177, Issue 1-2, 1997, Pages 69-77

  Vivas Mejía, Pablo E ^a,b   Rodríguez Cabán, Jorge L ^b   Díaz Velázquez, Magda ^a   Hernández Pérez, Melvin G ^a   Cox, Osvaldo ^b   Gonzalez, Fernando A ^b  

^a Department of Chemistry ^*  (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Anti neoplastic; DNA drug interaction; Molecular mechanism of drug action

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; DNA; INTERCALATING AGENT; QUINOLINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; DNA HELIX; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG SENSITIVITY; DRUG STRUCTURE; HELA CELL; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

EID: 0030778455     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1006857118469     Document Type: Article

References (45)

1. Krugh, TR: Oligonucleotide and polynucleotide-drug complex in solution as investigated by NMR. In: S Neidle (ed). Topics in Nucleic Acid Structure. Macmillan, New York, 1981, p 197
2. Wang JC: Unwinding of DNA by actinomycin D binding. Biochim Biophys Acta 2332: 246-251, 1971
3. Waring MJ, Wakelin LP: Echinomycin: a bifunctional intercalating antibiotic. Nature 252: 653-657, 1974
4. Fok JC, Waring MJ: Breakdown of pulse-labeled ribonucleic acids in Bacillus megaterium revealed by exposure to the antibiotics mithromycin, chromomycin, and nogalamycin. Mol Pharmacol 8: 65-74, 1972
5. Krugh TR: Drug-DNA interactions. Curr Opin Struct Biol 4: 351-364, 1994
6. Liu LF: DNA Topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58: 351-375, 1989
7. Waring MJ: DNA modification and cancer. Annu Rev Biochem. 50: 159-192, 1981
8. Zwelling LA, Michaels S, Erickson LC, Ungerleider RS, Nichols M, Kohn KW: Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4′-(9-acridinylamino) methanesulfon-m-aniside and adryamycin. Biochemistry 20: 6553-6563, 1981
9. Nelson EM, Tewey KM, Liu LF: Mechanism of antitumor drug action: Poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)methanesulfon-m-aniside. Proc Natl Acad Sci USA 81: 1361-1365, 1984
10. Cox O, Jackson H, Vargas VA, Báez A, Colón JI, González BC, De León M: Synthesis and biological activity of benzothiazolo and benzoxazolo[3,2-α]-quinolinium salts. J Med Chem 25: 1378-1381, 1982
11. Gonzalez FA, Llende M, Báez A, Ortiz JR: The antitumor drug 3-nitrobenzothiazolo[3,2-α]quinolinium chloride (NBQ): effects on lens regeneration and interaction with DNA of Notophtalmus viridescens. Differentiation 36: 125-129, 1987
12. Báez A, González FA, Vázquez D, Waring MJ: Interaction between a 3-nitrobenzothiazolo[3,2-α]quinolinium antitumor drug and deoxyribonucleic acid. Biochem Pharmacol 32: 2089-2094, 1983
13. Casiano-Torres CA, Báez A: Effects of the antitumor drugs 3-nitrobenzothiazolo [3,2-α]quinolinium and fagaronine on nucleic acid and protein synthesis. Biochem Pharmacol 35: 679-685, 1985
14. Herreño-Saenz D, Ortiz, JR, Báez A: Effects of the 3-nitrobenzothiazolo[3,2-́]quinolinium chloride (NBQ) and doxorubicin on lens regeneration in the adult newt: a morphological study. Differentiation 55: 169-174, 1994
15. Alegria AK, Cox O, Santiago V, Colon M, Reyes Z, Zayas L, Rivera LA, Dumas JA: Reductive activation of benzazolo[3,2-α]quinolinium chlorides. Free Radical Biol Med 15: 49-56, 1993
16. Báez A, JF, Riou JB, Le Pecq, Riou G: Interaction of DNA intercalator 3-nitrobenzothiazolo [3,2-α] quinolinium with DNA topoisomerases: A possible mechanism for its biological activity. Mol Pharmacol 37: 377-382, 1989
17. Cain BF, Atwell GJ: The experimental antitumor properties of three congeners of the acridylmethanesulphonanilide (AMSA) series. Eur J Cancer 10: 539-549, 1974
18. Skehan P, Storeng R, Scudiero D, Monks A, McMahom J, Vistica D, Warren J, Bokesch H, Kenney S, Boyd M: New colorimetric cytotoxicity assay for anticancer-drug screening. J Nat Cancer Inst 82: 1107-1112, 1990
19. Chavez P, Sánchez L, Rodriguez-C ab an JL, Gonzalez FA, Axelrod F : Cytotoxicity correlations of Puerto Rican plants using a simplified brine shrimp assay. Int J Pharmacog, in press, 1997
20. Peacocke AR, Skerrett JN: The interaction of aminoacridines with nucleic acids. Trans Faraday Soc 52: 261-279, 1956
21. Scatchard G.: The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51: 660-672, 1949
22. McGhee JD, Von Hippel PH: Theoretical aspects of DNA-protein interactions: cooperative and non-cooperative binding of large ligands to a one-dimensional homogeneous lattice. J Mol Biol 86: 469-489, 1974
23. Cohen G, Eisenberg H: Conformation studies on the sodium and cesium salts of calf thymus deoxyribonucleic acid (DNA). Biopolymers 4: 429-440, 1966
24. Porumb H: The solution spectroscopy of drugs and the drug-nucleic acid interactions. Prog Biophys Molec Biol 34: 175-195, 1978
25. Wakelin LP, Romanos M, Chen JK, Glaubiger D, Canellakis ES, Waring MJ: Structural limitations on the bifunctional intercalation of diacridines into DNA. Biochemistry 17: 5057-5063, 1978
26. Cox O, Prieto JA, Rodriguez M: Two-dimensional NMR analysis of selected benzazolo[3,2-α]quinolinium salts. Magn Res 27: 1094-1097
27. Marmur J: A procedure for the isolation of deoxyribonucleic acid from microorganisms. J Mol Biol 3: 208-218, 1961
28. Wakelin LP, Waring MJ: The unwinding of circular deoxyribonucleic acid by phenanthridium drugs: Structure-activity relations for the intercalation reaction. Mol Pharmacol 10: 544-561, 1974
29. Waring MJ: Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: Evidence for molecular models involving intercalation. J Mol Biol 54: 247-279, 1970
30. Lee JS, Waring MJ: Bifunctional intercalation and sequence specificity in the binding of quinomycin and triostin antibiotics to deoxyribonucleic acid. Biochem J 173: 115-128, 1978
31. Yamada T: Transdifferentiation of lens cells and its regulations. In: Cell biology of the eye. DS McDevitt (ed). Academic Press, New York, 1982, pp 193-242
32. Neidle S, Zelda A: Structural and sequence-dependent aspects of drug intercalation into nucleic acids. CRC Critical Reviews in Biochemistry 17: 73-121, 1985
33. Reinert KE: DNA stiffening and elongation caused by the binding of ethidium bromide. Biochim Biophys Acta 319: 135-139, 1973
34. Kumar GS, He QY, Behr-Ventura D, Tomasz M: Binding of 2, 7-Diaminomitosene to DNA: Model for the precovalent recognition of DNA by activated mitomycin C. Prog Biochemistry 34: 2662-2671, 1995
35. Elion GB: The purine path to chemotherapy. Science 244: 41, 1989
36. Sinha BK: Topoisomerase inhibitors: A review of their therapeutic potential in cancer. Drug 49: 11-19, 1995
37. Clark AJ: Mode of Action of Drugs on Cells. Arnold, London, 1993, pp 50-75
38. Ames M, Powis G, Kovach J: Pharmacokinetics of Anticancer Agents in Humans. Elsevier Science Publishers BV, Amsterdam, 1983, pp 3-28
39. Gabbay EJ, Grier RE, Reiner RL, Pearce SW, Wilson WD: Interaction specificity of the anthracyclines with deoxyribonucleic acid. Biochemistry 15: 2062-2070, 1976
40. Youngquist RS, Dervan PB: Sequence-specific recognition of B-DNA by oligo (N-methylpyrollecarboxamides). Proc Natl Acad Sci USA 82: 2565-2569, 1985
41. Van Dyke MW, Dervan PB: Chromomycin, mithramycin and olivomycin binding sites on heterogeneous deoxyribonucleic acid. Biochemistry 22: 2373-2377, 1983
42. Gellet M: DNA Topoisomerase. Annu Rev Biochem 50: 879-910, 1981
43. Wang JC: DNA Topoisomerases. Annu Rev Biochem 54: 665-697, 1985
44. Permana PA, Snapka RM, Shen LL, Chu TW, Clement JJ, Plattner JJ: Quinobenoxazines: A class of novel antitumor quinolines and potent mammalian DNA topoisomerase II catalytic inhibitors. Biochemistry 33: 11333-11339, 1994
45. Vivas-Mejía PE, Cox O, Gonzalez FA: Inhibition of topoisomerase II by antineoplastic benzazolo[3,2-α]quinolinium chlorides. Mol Cell Biochem, in press, 1997